Kenneth Chahine is the man behind AncestryDNA, the direct-to-consumer genetic genealogy product with more than 15 million users. The company recently launched Ancestry Health, which in part uses next-generation sequencing (NGS), but is priced under $100 […]

With a new CEO at its helm, Laboratory for Advanced Medicine is preparing to take on the cancer-diagnostics market. Former AncestryDNA executive Kenneth Chahine has joined the company as it plans to drive global commercialization of its artificial intelligence liquid biopsy pipeline […]

The surprise announcement by Biogen International about two weeks ago that it would work to register a drug for Alzheimer’s after nearly giving it up following a failed trial has again raised hopes of a dramatic change in this market. The Alzheimer’s market has not seen new drugs for many years, and companies that have buried hundreds […]